Drugs / Insulin faster aspart
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04772729 | Mar 2021 → Mar 2023 | type 1 diabetes mellitus | Medical University of Warsaw | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulin faster aspart | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04772729 ↗ |
| Known as | Fiasp | “Insulin faster aspart (Fiasp, Novo Nordisk)” NCT04772729 ↗ |
| Route | Subcutaneous | “continuous subcutaneous insulin infusion of insulin faster aspart” NCT04772729 ↗ |